Anya Biopharm (ROCO:7776) Marketable Securities: NT$220.02 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7776 Anya Biopharm Inc ROCO:7776
10 GF Score
Price NT$30.90
! 4 Warning Signs
View Full Analysis

What is Anya Biopharm Marketable Securities?

Anya Biopharm ROCO:7776 +1.64% 10 Marketable Securities is NT$220.02 Mil as of Dec. 2025. GuruFocus rates ROCO:7776 with a GF Score™ of 10/100. The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Anya Biopharm's Marketable Securities for the quarter that ended in Dec. 2025 was NT$220.02 Mil.

Anya Biopharm's annual Marketable Securities increased from Dec. 2023 (NT$0.51 Mil) to Dec. 2024 (NT$164.43 Mil) and increased from Dec. 2024 (NT$164.43 Mil) to Dec. 2025 (NT$220.02 Mil).

Anya Biopharm  (ROCO:7776) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Anya Biopharm Marketable Securities Related Terms

Anya Biopharm Marketable Securities Historical Data

* Premium members only.

The historical data trend for Anya Biopharm's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anya Biopharm Marketable Securities Chart

Anya Biopharm Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Marketable Securities
0.49 0.51 164.43 220.02

Anya Biopharm Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Marketable Securities Get a 7-Day Free Trial 0.51 0.52 164.43 146.66 220.02
ROCO:7776
10GF Score
Anya Biopharm Inc ROCO:7776
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anya Biopharm Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of NT$220.02 Mil mean?
Anya Biopharm (ROCO:7776) has a Marketable Securities of NT$220.02 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Anya Biopharm and its competitors.
Is Anya Biopharm's Marketable Securities too high?
Anya Biopharm's current Marketable Securities is NT$220.02 Mil. Overall, Anya Biopharm has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Anya Biopharm's Marketable Securities compare to VRTX and REGN?
Anya Biopharm's Marketable Securities of NT$220.02 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Anya Biopharm and its competitors. Anya Biopharm's current Marketable Securities is NT$220.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anya Biopharm stock overvalued right now?
Anya Biopharm (ROCO:7776) has a current Marketable Securities of NT$220.02 Mil. The current Marketable Securities is NT$220.02 Mil. Anya Biopharm's overall GF Score™ is 10/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Anya Biopharm (ROCO:7776), the current Marketable Securities is NT$220.02 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anya Biopharm Business Description

Address No. 3-2, Yuanqu Street, 4th Floor, Nangang, Taipei, TWN, 115603
Anya Biopharm Inc is a pharmaceutical company engaged in the Oral Delivery of Peptides. Its patented technology platform Mira/Je is a flexible solution easy to adapt to a large variety of peptides.
10GF Score

Get the complete analysis for ROCO:7776

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$30.90
Price